Anti-Methadone (MD-9941)
Anti-Methadone (MD-9941)
Product No.: M228
- -
- -
Clone MD-9941 Target Methadone Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Isotype Mouse IgG2b κ Applications ELISA , Lateral Flow |
- -
- -
Antibody DetailsProduct DetailsProduct Concentration ≥1.0 mg/ml Purity >98% by SDS Page Formulation Formulated in phosphate buffered saline, pH 7.0 and contains 0.05% sodium azide. State of Matter Liquid Product Preparation This monoclonal antibody is purified by Protein A chromatography. Storage and Handling 2-8ºC Regulatory Status Research Use Only Country of Origin USA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Anti-Methadone (Clone MD-9941) is specific for methadone. Background Methadone is a synthetic opioid primarily utilized in the treatment of opioid dependence, particularly for individuals undergoing medication-assisted treatment (MAT) but is also used to treat chronic pain. Methadone has become a cornerstone in managing opioid addiction by alleviating withdrawal symptoms and reducing cravings. It acts on the same opioid receptors as heroin and other opioids, providing a stable and controlled substitute. Diagnostic testing for methadone involves urine screenings to monitor adherence to treatment plans and detect any concurrent substance use. These tests aim to ensure that individuals prescribed methadone are receiving the appropriate dosage and are not engaging in illicit drug use. Methadone's inclusion in routine drug testing for those undergoing MAT is crucial for healthcare providers to assess the effectiveness of treatment and address any potential complications arising from non-compliance or additional substance use. Antigen DetailsResearch Area Drug of Abuse . Matched Pair . IVD Raw Material References & Citations1. Durrani M, Bansal K. Methadone. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Link Technical Protocols |
Formats Available
